NFE2L2 and chronic kidney disease: Future research that can explore Nrf2 functionally deficient models, more types of renal cells, and chronic kidney disease models in vivo (especially those that simulate IS accumulation) will be significant in confirming the therapeutic significance of AST and determining whether its protective effect on the kidney is applicable in different types of chronic kidney disease etiologies.